Trial Profile

A clinical study of PMI21 in patients with metastatic prostate cancer

Status: Planning

Phase of Trial: Phase I

Latest Information Update: 27 Jan 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs PMI 21 (Primary)
Indications Prostate cancer
Focus Adverse reactions

Most Recent Events

26 Jan 2022 According to an IONETIX media release, the company expect to initiate this trial later this year.
29 Dec 2021 New trial record
21 Dec 2021 According to a Precision Molecular media release, the company expects to start this study in first half of next year, 2022.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com